Good health is vital to all of us, and finding sustainable solutions to the most pressing health care challenges cannot wait. That's why we at Adley are committed to applying science and our resources to improve health and well-being at every stage of life. ADLEY is an integrated, research based, pharmaceutical company, producing a wide range of quality, affordable medicines, trusted by healthcare professionals and patients across geographies.
ADLEY has a footprint in all states of India, and is gradually making a dent in the international market.We have a leading portfolio of products and medicines that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas; and we have an industry-leading pipeline of promising new products that have the potential to challeng some of the most feared diseases of our time, like cancer.
To ensure we can continue to deliver on our commitments to the patients, customers who rely on us, we are focused on improving the way we do business; on operating with transparency in everything we do; and on listening to the views of all of the people involved in health care decisions. Through working in partnership with everyone from patients to health care providers and managed care organizations to international bodies, our goal is to ensure that people everywhere have access to affordable treatments and quality health care.
Our diversified health care portfolio includes human and animal biologic and Adley supply chain partners work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the leading pharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care.
Adley Group is the leading pharmaceutical company, marketing products from a wide range of therapeutic areas including cardiovascular, anti-infective, CNS, antiinflammatory, oncolytic, anti-diabetic, analgesic, dermatology, respiratory, and women's health. Dosage forms include tablets and capsules, injectables, creams, ointments, solutions, and suspensions. Adley products are marketed to chains, wholesalers,distributors, and government agencies, as well as in health systems and oncology
Adley is focused on increasing the momentum in the pharmaceutical business in its key markets through organic and inorganic growth routes. Growth is well spread across geographies with focus on emerging markets. The Company continues to evaluate other dosage forms which presently are not part of present production platform ADLEY has forayed into high growth potential segments like Biologic, Oncology and injection. Dedicated manufacturing facilities of oncology products in the dosage forms of capsules and tablets will fetch additional market share with additional of our next expansion for oncology API in Punjab, Group is very much positive to to increase the revenue generation , economies of scale and profitability of whole group. These new growth areas will add significant depth to the existing product pipeline.
Adley formulations offers a wide range of anti cancer supportive products which includes adcumin gel. Feature: it is is a potent anti-inflammatory with specific lipoxygenase – and c0x-2 inhibiting pro ...
Adley formulations offers a wide range of anti cancer supportive products which includes adcumin syrup. Feature: it is specially designed nanocurcumin, better bioavailabilty, active in all major pro-i ...